greeksoup/ stock research

Intuitive Surgical (ISRG) FY2024 results: revenue $8.4 billion, up 17.2% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $8.4 billion for fiscal 2024, the year ended 31 December 2024, up 17.2% on the year before. Net income was $2.3 billion, up 29.2%, and diluted earnings per share $6.42. The figures are the company's own, from the 10-K it filed with the SEC on 31 January 2025.

Revenue
$8.4 billion
+17.2% on the year
FY2017FY2024
Operating margin
28.1%
24.8% a year earlier
FY2017FY2024
Net income
$2.3 billion
+29.2% on the year
FY2017FY2024
Diluted EPS
$6.42
+27.6% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue8,3527,1246,222+17.2%
Cost of revenue2,7182,3952,026+13.5%
Gross profit5,6344,7304,196+19.1%
Gross margin67.5%66.4%67.4%
Research and development1,145999879+14.7%
Selling, general and administrative2,1401,9641,740+9.0%
Operating income2,3491,7671,577+32.9%
Operating margin28.1%24.8%25.3%
Pre-tax income2,6741,9591,607+36.5%
Income tax336142262+137.5%
Effective tax rate12.6%7.2%16.3%
Net income2,3231,7981,322+29.2%
Net margin27.8%25.2%21.3%
Diluted EPS$6.42$5.03$3.65+27.6%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow2,4151,8141,491+33.1%
Capital expenditure1,1111,064532+4.4%
Free cash flow1,304750958+73.9%
Free cash flow margin15.6%10.5%15.4%
Cash from investing-3,273-3601,371
Cash from financing151-288-2,572
Depreciation and amortisation456402354+13.3%
Share-based compensation677593513+14.2%
Buybacks0.04162,607
Diluted shares, weighted362m357m362m+1.3%
Shares outstanding at period end357m352m350m+1.2%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity16,43413,30811,042+23.5%
Non-controlling interest95.989.770.7+6.9%
Debt0.00.00.0
Operating lease liabilities11264.569.6+74.4%
Other liabilities2,1011,9801,792+6.1%
Total liabilities and equity18,74315,44212,974+21.4%
Fixed assets4,6473,5382,374+31.3%
Goodwill348349348-0.3%
Intangible assets23.039.149.8-41.2%
Investments6,8054,5935,160+48.2%
Cash and equivalents2,0272,7501,581-26.3%
Receivables1,2251,130942+8.4%
Inventory1,4871,221893+21.8%
Other assets2,1811,8221,625+19.7%
Total assets18,74315,44212,974+21.4%

10-K for the year ended 31 December 2024, filed 31 January 2025: the filing.